A Phase 3, Open-Label, Multicenter Study of a 6-Month Pre-Mixed Depot Formulation of Leuprolide Mesylate in Advanced Prostate Cancer Patients

World Journal of Urology - Germany
doi 10.1007/s00345-019-02741-7
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ceritinib Plus Nivolumab in Patients With Advanced ALK-rearranged Non-Small-Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2020English

Infliximab for Pediatric Patients With Ulcerative Colitis: A Phase 3, Open-Label, Uncontrolled, Multicenter Trial in Japan

BMC Pediatrics
Child HealthPediatricsPerinatology
2019English

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

SAT0231 Safety of Subcutaneous Belimumab in Patients With Systemic Lupus Erythematosus: A 6-Month Open-Label Extension Study

2017English

A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2016English

P1.01-32 a Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients With Interstitial Lung Disease

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Phase I Open Label Study of the Farnesyltransferase Inhibitor CP-609,754 in Patients With Advanced Malignant Tumors

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

The First-In-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients With Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy